Jounce Therapeutics, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Jounce Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $35 million sold in a notice filed in 2020.
Jounce Therapeutics at a glance
What does Jounce Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $35 million sold (2020).
Frequently asked questions about Jounce Therapeutics
Where is Jounce Therapeutics headquartered?
Jounce Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Jounce Therapeutics do?
Jounce Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Jounce Therapeutics founded?
The earliest incorporation on record for Jounce Therapeutics, Inc. is in 2012, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences